Using the TCGA dataset, we found that higher SOX9 levels in tumor samples correlated with greater enrichment of the molecular signatures of normal ER− luminal cells and ER− tumors (Figure S2D), in agreement with a previous study with a small number of tumor samples (Domenici et al., 2019). Here, SOX9 is linked to neoplasm.